Trials / Unknown
UnknownNCT03047304
Magnesium Effect on Embryonal PR Interval
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 25 (estimated)
- Sponsor
- Rambam Health Care Campus · Academic / Other
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
Magnesium is a known treatment for neuroprotection in preterm labor before 32 week of gestation. High concentration of Magnesium in the blood stream known as cause of conduction abnormalities and ECG changes such us prolonged QT, QRS and PR in about. The goal of our work is to evaluate the PR intervals in embryos after maternal treatment with magnesium during preterm labor.
Detailed description
We will recruit 25 woman with threaten preterm labor, magnesium blood level and PR interval will be evaluated before magnesium loading dose (4gr) and 20 minutes after the loading dose. PR interval will be evaluated by Mitral-Aorta Doppler.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Trans abdominal sonography | Trans abdominal sonography in order to measure fetal PR interval. |
Timeline
- Start date
- 2017-02-14
- Primary completion
- 2018-02-10
- Completion
- 2018-03-10
- First posted
- 2017-02-08
- Last updated
- 2017-02-15
Source: ClinicalTrials.gov record NCT03047304. Inclusion in this directory is not an endorsement.